Skip to main content

Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • BofA Securities Health Care Conference, Las Vegas

    Fireside chat on Wednesday, May 14, 2025 at 1:40 p.m. ET (10:40 a.m. PT)

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.42
-3.96 (-1.70%)
AAPL  281.72
-2.43 (-0.86%)
AMD  215.45
-2.15 (-0.99%)
BAC  54.47
+0.38 (0.69%)
GOOG  317.48
-3.14 (-0.98%)
META  667.00
+27.39 (4.28%)
MSFT  478.59
+0.86 (0.18%)
NVDA  181.02
+1.43 (0.80%)
ORCL  208.64
+0.91 (0.44%)
TSLA  451.97
+5.23 (1.17%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.